Aspiriant Risk-Managed Equity Allocation Fund MRVL Holdings History
Aspiriant Risk-Managed Equity Allocation Fund's Marvell Technology Inc Holding Summary
As of 2025-03-31, Aspiriant Trust held - shares of Marvell Technology Inc(MRVL), totaling N/A. This investment constitutes 0% of their stock portfolio, and Aspiriant Trust now holds 0% of the outstanding Marvell Technology Inc(MRVL) stock.
The initial trade took place in 2020Q2. And since then Aspiriant Risk-Managed Equity Allocation Fund has made 4 purchases of MRVL, at an average price of $45.36, for a total of 54,056.00 shares. In addition, there have been 4 sales at an average price of $77.31 for 54,056.00 shares. Based on historical transaction data and MRVL's current price of $72.03, Aspiriant Risk-Managed Equity Allocation Fund's estimated gain on his MRVL holdings is $1.73 Mil, reflecting a 70.43% gain to date.
Aspiriant Risk-Managed Equity Allocation Fund MRVL ($72.03) Holding Chart
Aspiriant Risk-Managed Equity Allocation Fund MRVL ($72.03) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
